1. https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/pipeline-tracker
2. https://www.airfinity.com/insights/more-than-a-billion-available-stock-of-western-covid-19-vaccines-by-the-end
3. https://www.bloomberg.com/news/articles/2022-05-03/aspen-may-close-covid-vaccine-line-within-weeks-as-talks-drag
4. https://geneva-network.com/research/joint-declaration-on-the-importance-of-intellectual-property-rights-in-advancing-equitable-access-to-vaccines-and-therapeutics-for-pandemic-preparedness/
5. https://geneva-network.com/research/the-role-of-intellectual-property-rights-in-preparing-for-future-pandemicss/
6. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30346-2/fulltext
7. https://absolutelymaybe.plos.org/2022/01/30/new-triumphs-struggles-for-non-profit-covid-vaxes/
8. https://absolutelymaybe.plos.org/2022/01/30/new-triumphs-struggles-for-non-profit-covid-vaxes/
9. Park, Alice, and Aryn Baker. “Exclusive: Inside the Facilities Making the World’s Most Prevalent COVID-19 Vaccine.” Time, April 19, 2021. https://time.com/5955247/inside-biontech-vaccine-facility/. Neubert and Scheitz, “Exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 Vaccines.”
10. https://geneva-network.com/research/trade-secrecy-and-covid-19/#_edn38
11. https://www.bloomberg.com/news/articles/2020-11-18/covid-vaccine-race-has-one-more-obstacle-to-overcome-bureaucracy
12. https://www.icmra.info/drupal/en/news/March2020